176 related articles for article (PubMed ID: 20835854)
21. A novel mutation in the SLC19A2 gene in a Turkish male with thiamine-responsive megaloblastic anemia syndrome.
Odaman-Al I; Gezdirici A; Yıldız M; Ersoy G; Aydoğan G; Şalcıoğlu Z; Tahtakesen TN; Önal H; Küçükemre-Aydın B
Turk J Pediatr; 2019; 61(2):257-260. PubMed ID: 31951337
[TBL] [Abstract][Full Text] [Related]
22. Leber congenital amaurosis as an initial manifestation in a Chinese patient with thiamine-responsive megaloblastic anemia syndrome.
Wu S; Yuan Z; Sun Z; Yao F; Sui R
Am J Med Genet A; 2022 Mar; 188(3):948-952. PubMed ID: 34821467
[TBL] [Abstract][Full Text] [Related]
23. Thiamine responsive megaloblastic anemia syndrome.
Ganesh R; Ezhilarasi S; Vasanthi T; Gowrishankar K; Rajajee S
Indian J Pediatr; 2009 Mar; 76(3):313-4. PubMed ID: 19347672
[TBL] [Abstract][Full Text] [Related]
24. Novel nonsense mutation (p.Ile411Metfs*12) in the SLC19A2 gene causing Thiamine Responsive Megaloblastic Anemia in an Indian patient.
Manimaran P; Subramanian VS; Karthi S; Gandhimathi K; Varalakshmi P; Ganesh R; Rathinavel A; Said HM; Ashokkumar B
Clin Chim Acta; 2016 Jan; 452():44-9. PubMed ID: 26549656
[TBL] [Abstract][Full Text] [Related]
25. Arrhythmia in thiamine responsive megaloblastic anemia syndrome.
Argun M; Baykan A; Hatipoğlu N; Akın L; Şahin Y; Narin N; Kurtoğlu S
Turk J Pediatr; 2018; 60(3):348-351. PubMed ID: 30511554
[TBL] [Abstract][Full Text] [Related]
26. Thiamine responsive megaloblastic anemia syndrome: a novel homozygous SLC19A2 gene mutation identified.
Mikstiene V; Songailiene J; Byckova J; Rutkauskiene G; Jasinskiene E; Verkauskiene R; Lesinskas E; Utkus A
Am J Med Genet A; 2015 Jul; 167(7):1605-9. PubMed ID: 25707023
[TBL] [Abstract][Full Text] [Related]
27. Beta cell function and clinical course in three siblings with thiamine-responsive megaloblastic anemia (TRMA) treated with thiamine supplementation.
Potter K; Wu J; Lauzon J; Ho J
J Pediatr Endocrinol Metab; 2017 Feb; 30(2):241-246. PubMed ID: 28076318
[TBL] [Abstract][Full Text] [Related]
28. Whole exome sequencing identifies a new mutation in the SLC19A2 gene leading to thiamine-responsive megaloblastic anemia in an Egyptian family.
Amr K; Pawlikowska P; Aoufouchi S; Rosselli F; El-Kamah G
Mol Genet Genomic Med; 2019 Jul; 7(7):e00777. PubMed ID: 31144472
[TBL] [Abstract][Full Text] [Related]
29. Thiamine-Responsive Megaloblastic Anaemia With Hypothyroidism, A Puzzling Association.
Rai VR; Ibrahim MN; Javed MN; Khoso Z; Rathore H
J Ayub Med Coll Abbottabad; 2023; 35(Suppl 1)(4):S804-S806. PubMed ID: 38406914
[TBL] [Abstract][Full Text] [Related]
30. Thiamine responsive megaloblastic anaemia complicated with acute Parvovirus infection: A case report.
Khaliq S
J Pak Med Assoc; 2023 Jan; 73(1):162-164. PubMed ID: 36842030
[TBL] [Abstract][Full Text] [Related]
31. Novel mutation in the SLC19A2 gene in an Iranian family with thiamine-responsive megaloblastic anemia: a series of three cases.
Ghaemi N; Ghahraman M; Abbaszadegan MR; Baradaran-Heravi A; Vakili R
J Clin Res Pediatr Endocrinol; 2013 Sep; 5(3):199-201. PubMed ID: 24072090
[TBL] [Abstract][Full Text] [Related]
32. Novel mutation in the SLC19A2 gene in an African-American female with thiamine-responsive megaloblastic anemia syndrome.
Lagarde WH; Underwood LE; Moats-Staats BM; Calikoglu AS
Am J Med Genet A; 2004 Mar; 125A(3):299-305. PubMed ID: 14994241
[TBL] [Abstract][Full Text] [Related]
33. A novel mutation in the SLC19A2 gene in a Turkish female with thiamine-responsive megaloblastic anemia syndrome.
Yeşilkaya E; Bideci A; Temizkan M; Kaya Z; Camurdan O; Koç A; Bozkaya D; Koçak U; Cinaz P
J Trop Pediatr; 2009 Aug; 55(4):265-7. PubMed ID: 18614593
[TBL] [Abstract][Full Text] [Related]
34. An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
Di Candia F; Di Iorio V; Tinto N; Bonfanti R; Iovino C; Rosanio FM; Fedi L; Iafusco F; Arrigoni F; Malesci R; Simonelli F; Rigamonti A; Franzese A; Mozzillo E
Ital J Pediatr; 2023 Nov; 49(1):158. PubMed ID: 38037112
[TBL] [Abstract][Full Text] [Related]
35. Identification of four SLC19A2 mutations in four Chinese thiamine responsive megaloblastic anemia patients without diabetes.
Liu G; Yang F; Han B; Liu J; Nie G
Blood Cells Mol Dis; 2014 Apr; 52(4):203-4. PubMed ID: 24355766
[No Abstract] [Full Text] [Related]
36. Identification of novel compound heterozygous variants in SLC19A2 and the genotype-phenotype associations in thiamine-responsive megaloblastic anemia.
Zhang S; Qiao Y; Wang Z; Zhuang J; Sun Y; Shang X; Li G
Clin Chim Acta; 2021 May; 516():157-168. PubMed ID: 33571483
[TBL] [Abstract][Full Text] [Related]
37. Neonatal diabetes mellitus: remission induced by novel therapy.
Dalwadi P; Joshi AS; Thakur DS; Bhagwat NM
BMJ Case Rep; 2019 Jun; 12(6):. PubMed ID: 31243025
[TBL] [Abstract][Full Text] [Related]
38. A rare case of thiamine-responsive megaloblastic anaemia syndrome: a disorder of high-affinity thiamine transport.
Naeem MA; Shabaz A; Shoaib A; Usman M
J Ayub Med Coll Abbottabad; 2008; 20(3):146-8. PubMed ID: 19610542
[TBL] [Abstract][Full Text] [Related]
39. Rare case with megaloblastic anaemia.
Saleem M; Shah SS; Mehmood T
J Ayub Med Coll Abbottabad; 2014; 26(1):104-5. PubMed ID: 25358233
[TBL] [Abstract][Full Text] [Related]
40. Diabetic acido-ketosis revealing thiamine-responsive megaloblastic anemia.
Bouyahia O; Ouderni M; Ben Mansour F; Matoussi N; Khaldi F
Ann Endocrinol (Paris); 2009 Dec; 70(6):477-9. PubMed ID: 19922902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
